Advanced search
Publication Cover
Hematology Volume 28, 2023 - Issue 1
Submit an article Journal homepage
1,310
Views
0
CrossRef citations to date
0
Altmetric
Research Article

Dual inhibition of STAT3 and STAT5 may overcome imatinib resistance in chronic myeloid leukemia

Lingling Yina Department of Hematology, The Affiliated Hospital of Xuzhou Medical University, Xuzhou, People’s Republic of China;b Blood Diseases Institute, Xuzhou Medical University, Xuzhou, People’s Republic of China;c Key Laboratory of Bone Marrow Stem Cells, Xuzhou, People’s Republic of ChinaView further author information
,
Jiawen Xub Blood Diseases Institute, Xuzhou Medical University, Xuzhou, People’s Republic of China;c Key Laboratory of Bone Marrow Stem Cells, Xuzhou, People’s Republic of ChinaView further author information
,
Wenjian Wud Medical Record and Statistical Office, The Affiliated Hospital of Xuzhou Medical University, Xuzhou, People’s Republic of ChinaView further author information
,
Mingshan Niua Department of Hematology, The Affiliated Hospital of Xuzhou Medical University, Xuzhou, People’s Republic of China;b Blood Diseases Institute, Xuzhou Medical University, Xuzhou, People’s Republic of China;c Key Laboratory of Bone Marrow Stem Cells, Xuzhou, People’s Republic of ChinaView further author information
,
Zhenyu Lia Department of Hematology, The Affiliated Hospital of Xuzhou Medical University, Xuzhou, People’s Republic of China;b Blood Diseases Institute, Xuzhou Medical University, Xuzhou, People’s Republic of China;c Key Laboratory of Bone Marrow Stem Cells, Xuzhou, People’s Republic of ChinaView further author information
,
Feng Zhua Department of Hematology, The Affiliated Hospital of Xuzhou Medical University, Xuzhou, People’s Republic of China;b Blood Diseases Institute, Xuzhou Medical University, Xuzhou, People’s Republic of China;c Key Laboratory of Bone Marrow Stem Cells, Xuzhou, People’s Republic of ChinaCorrespondence[email protected]
View further author information
&
Kailin Xua Department of Hematology, The Affiliated Hospital of Xuzhou Medical University, Xuzhou, People’s Republic of China;b Blood Diseases Institute, Xuzhou Medical University, Xuzhou, People’s Republic of China;c Key Laboratory of Bone Marrow Stem Cells, Xuzhou, People’s Republic of ChinaView further author information
 show all
Article: 2224625 | Received 03 Nov 2022, Accepted 22 Apr 2023, Published online: 22 Jun 2023

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.